Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation123
Under an Elsevier user license
open archive
Cited by (0)
- 1
From InteKrin Therapeutics Inc, Los Altos, CA.
- 2
Presented at the symposium ‘‘Novel Therapeutic Advances through the Development of Selective PPARc Modulators from Bench to Bedside,’’ held at Experimental Biology 2009, New Orleans, LA, 21 April 2009.
- 3
Address correspondence and reprint requests to LS Higgins, InteKrin Therapeutics Inc, 4300 El Camino Real, Suite 201, Los Altos, CA 94022. E-mail: [email protected].
Copyright © 2010 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.